Certara Hosts Seminar on Drug Discovery Challenges in Japan and How Modeling and Simulation Can Solve Them
“Quantitative decision-making with data rather than empirical thinking" - Certara's Modeling & Simulation technology contributes…
Certara2022年9月13日
Navigating the Biotech Funding Crunch: How to Achieve Your Next Value Inflection
For the past two years, the biotech sector saw a surge of venture funding and…
Certara2022年8月30日
3 Major Implications of New European Clinical Trial Regulations
Have you heard the buzz around the new European Union Clinical Trial Regulations (EU-CTR) for…
Certara2022年8月25日
Mind-blowing applications of QSP in drug development: Part 2
Part 2 of this blog series dives further into the June 2022 podcast with R&D…
Certara2022年8月15日
臨床薬理学および医薬品開発において、ヒトの放射性標識マスバランス試験が重要な理由
Human mass-balance studies are also called “C-14 studies” or “Absorption, Metabolism, and Excretion (AME) studies.”…
Certara2022年8月5日
Mind-blowing applications of QSP in drug development: Part 1
R&D World editors, Paul Heney and Aimee Kalnoskas, have their minds blown — multiple times!…
Certara2022年8月4日
How Pharmaceutical Companies Can Engage Payers Digitally
Pharmaceutical companies should seize opportunities to digitally engage with payers globally using both face-to-face and…
Certara2022年7月29日
How the Simcyp Discovery Simulator will Accelerate Early Drug Development
Physiologically-based pharmacokinetic (PBPK) modeling is a technique used to predict the absorption, distribution, metabolism, and…
Certara2022年7月19日
